BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Oct 27, 2011)

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on October 27, 2011, to report its financial results for the third quarter of 2011. The filing includes a press release detailing these results, which is incorporated by reference as Exhibit 99.1. Investors should note that this 8-K primarily serves as a notification and provides access to the company's detailed quarterly financial performance as communicated in the accompanying press release and supplemental information. While the 8-K itself does not contain the specific financial figures, it directs stakeholders to where this crucial data can be found, enabling them to assess the company's operational performance and financial condition for the period.

Key Highlights

• 1BMY filed an 8-K on October 27, 2011, to announce its third quarter 2011 financial results.
• 2The primary purpose of the filing is to furnish the official press release containing the company's Q3 2011 financial performance.
• 3Exhibit 99.1 is the press release detailing the third quarter 2011 financial results.
• 4Exhibit 99.2 includes supplemental financial information available on the company's website.
• 5The filing itself does not contain detailed financial data but directs investors to the provided exhibits for this information.
• 6This report is crucial for investors seeking to understand BMY's performance during the third quarter of 2011.

Frequently Asked Questions